ProMIS Neurosciences annual free cash flow
2021
2022
ProMIS Neurosciences Free Cash Flow (FCF) History (PMN)
ProMIS Neurosciences reported −$17.0M in free cash flow for fiscal 2022, a decrease of $7.7M from the previous fiscal year.
View full ProMIS Neurosciences company overviewProMIS Neurosciences free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2022 | 2022-12-31 | −$17.0M | −$7.7M | — | — |
| 2021 | 2021-12-31 | −$9.3M | — | — | — |
ProMIS Neurosciences quarterly free cash flow
Q1.22
Q2.22
Q3.22
Q4.22
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q4 2022 | 2022-12-31 | −$4.6M | — | — | — |
| Q3 2022 | 2022-09-30 | −$4.6M | — | — | — |
| Q2 2022 | 2022-06-30 | −$4.5M | — | — | — |
| Q1 2022 | 2022-03-31 | −$3.4M | — | — | — |
ProMIS Neurosciences free cash flow growth trends
ProMIS Neurosciences's latest reported quarter, Q4 2022, generated −$4.6M in free cash flow.
About the metric
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
Calculation and source
How free cash flow is calculated
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review ProMIS Neurosciences filings at SEC.gov ↗